Mg2+ dependency of HIV-1 reverse transcription, inhibition by nucleoside analogues and resistance

被引:45
作者
Goldschmidt, V [1 ]
Didierjean, J [1 ]
Ehresmann, B [1 ]
Ehresmann, C [1 ]
Isel, C [1 ]
Marquet, R [1 ]
机构
[1] Univ Strasbourg, UPR 9002, CNRS, IBMC, F-67084 Strasbourg, France
关键词
D O I
10.1093/nar/gkj411
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metal ions are essential for DNA polymerase and RNase H activities of HIV-1 reverse transcriptase (RT). RT studies are routinely performed at 6-8 mM Mg2+, despite the fact that the in vivo concentration might be as low as 0.2 mM. We studied the influence of MgCl2 and ATP, which likely binds a significant fraction of the magnesium pool in vivo, on the DNA polymerase and RNase H activities of HIV-1 RT, its inhibition by nucleoside RT inhibitors (NRTIs) and primer unblocking by AZT-resistant RT. At low Mg2+ concentration, reverse transcription of a natural template strongly increased despite a dramatically reduced intrinsic polymerase activity under such conditions. Low Mg2+ concentrations affected the RNA stability and indirectly decreased its degradation by the RNase H activity. The reduced RNA degradation prevented premature dissociation of the template and primer strands that otherwise generated dead-end DNA products. In addition, low Mg2+ dramatically decreased the incorporation of NRTIs into DNA and increased nucleotide excision by AZT-resistant RT. The latter effect is also most likely owing to the diminished cleavage of the RNA template. Thus, differences in the free Mg2+ concentration between different cell types or during the cell cycle might strongly affect HIV-1 replication and its inhibition.
引用
收藏
页码:42 / 52
页数:11
相关论文
共 47 条
[1]  
Arts EJ, 1998, PROG NUCLEIC ACID RE, V58, P339
[2]   FUNCTIONAL SITES IN THE 5' REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FORM DEFINED STRUCTURAL DOMAINS [J].
BAUDIN, F ;
MARQUET, R ;
ISEL, C ;
DARLIX, JL ;
EHRESMANN, B ;
EHRESMANN, C .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 229 (02) :382-397
[3]   The blood brain barrier in HIV infection [J].
Berger, JR ;
Avison, M .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 :2680-2685
[4]   Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase [J].
Boyer, PL ;
Sarafianos, SG ;
Arnold, E ;
Hughes, SH .
JOURNAL OF VIROLOGY, 2001, 75 (10) :4832-4842
[5]   DIVALENT-CATION MODULATION OF THE RIBONUCLEASE FUNCTIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE [J].
CIRINO, NM ;
CAMERON, CE ;
SMITH, JS ;
RAUSCH, JW ;
ROTH, MJ ;
BENKOVIC, SJ ;
LEGRICE, SFJ .
BIOCHEMISTRY, 1995, 34 (31) :9936-9943
[6]   Mutations in the ribonuclease H active site of HIV-RT reveal a role for this site in stabilizing enzyme-primer-template binding [J].
Cristofaro, JV ;
Rausch, JW ;
Le Grice, SFJ ;
DeStefano, JJ .
BIOCHEMISTRY, 2002, 41 (36) :10968-10975
[7]   BROAD-SPECTRUM ANTIRETROVIRAL ACTIVITY OF 2',3'-DIDEOXYNUCLEOSIDES [J].
DAHLBERG, JE ;
MITSUYA, H ;
BLAM, SB ;
BRODER, S ;
AARONSON, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (08) :2469-2473
[8]   CRYSTAL-STRUCTURE OF THE RIBONUCLEASE-H DOMAIN OF HIV-1 REVERSE-TRANSCRIPTASE [J].
DAVIES, JF ;
HOSTOMSKA, Z ;
HOSTOMSKY, Z ;
JORDAN, SR ;
MATTHEWS, DA .
SCIENCE, 1991, 252 (5002) :88-95
[9]   Catecholamine-induced regulation in vitro and ex vivo of intralymphocyte ionized magnesium [J].
Delva, P ;
Pastori, C ;
Degan, M ;
Montesi, G ;
Lechi, A .
JOURNAL OF MEMBRANE BIOLOGY, 2004, 199 (03) :163-171
[10]   Mechanistic insights into the suppression of drug resistance by human immunodeficiency virus type 1 reverse transcriptase using α-boranophosphate nucleoside analogs [J].
Deval, J ;
Alvarez, K ;
Selmi, B ;
Bermond, M ;
Boretto, J ;
Guerreiro, C ;
Mulard, L ;
Canard, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (05) :3838-3846